The Prostate health Market crossed US$ 35.01 billion mark in 2022 and is expected to hit US$ 70.08 billion by 2030, recording a CAGR of 9.1% during the forecast period.
Increasing prevalence of prostate cancer, growing research environment, increased number of grants, funds, and investments for R&D activities for BPH treatment, and rising demand for hormone therapy drugs are some of the major factors driving the growth of the prostate health market. For instance, according to American Cancer Society (ACS), about 1 man in 8 is expected to diagnosed with prostate cancer during his lifetime. About 6 cases in 10 are diagnosed in men who are 65 or older, and it is rare in men under 40. This research report provides insights into the “Prostate health Market.” This report summarizes the results of the assessment carried out by Business Market Insights in the field of the Benefits Management Platform for the global perspective. The report provides an analysis of the Benefits Prostate health Market by deployment, application, and geography.
Get Exclusive Sample Pages of Prostate health Market @: https://www.businessmarketinsights.com/sample/BMIRE00026482
- GlaxoSmithKline plc.
- Eli Lilly and Company
- Astellas Pharma Inc.
- Pfizer Inc.
- Merck & Co., Inc.
- AstraZeneca PLC
- Bayer AG
- Bristol-Myers Squibb Co.
Recent strategic developments in prostate health market
The prostate health market has undergone several significant developments, and a few of these have been mentioned below:
- In December 2021, The US Food and Drug Administration (FDA) has approved Accutar Biotechnology’s Investigational New Drug (IND) application for Phase I clinical trial of AC0176 to treat metastatic castration-resistant prostate cancer (mCRPC).
- In January 2021, Myovant announced its partnership with Pfizer to introduce its drug Orgovyx (relugolix).
- In June 2021, Novartis announced that the FDA had approved 177Lu-PSMA-617, experimental device therapy to treat metastatic castration-resistant prostate cancer (mCRPC).
- In 2020, Asahi Kasei Pharma obtained new drug approval in China for Flivas (naftopidil), an agent for treating dysuria associated with BPH.
Target audience for the report:
- API manufacturers
- Pharmaceutical companies
- Biopharmaceutical Companies
- Packaging providers
- Drug-related associations, organizations, forums, and alliances
- Government bodies, such as regulating authorities and policy makers
- Venture capitalists, private equity firms, and start-up companies
- Research institutes, organizations, and consulting companies
Scope of the report:
In this report, the market has been segmented on the basis of:
- Disease Indication:
- Benign prostatic hyperplasia (BPH)
- Prostate cancer
- 5 Alpha Reductase
- Cytotoxic Agents
- PARP Inhibitors
- Hormone ADT
- North America
- Asia Pacific (APAC)
- South & Central America
- Middle East & Africa
The report provides the current market size for the Prostate health Market, defines trends, and presents growth forecasts for nine years from 2022 to 2030. 2022 is considered as the base year, and 2022 to 2030 is the forecast year for the entire report. All the market numbers for revenue are provided in US dollars. The market is analyzed by the supply side, considering the market penetration of Benefits Management Platform for all the regions globally.
This research report on the “Prostate health Market” provides a holistic view of the global market size across major regions. The report further elucidates the key driving factors, restraints, growth opportunities, and future trends about the market growth. The market is segmented into deployment, application, and geography.
Prostate health Market Research Report Scenario includes:
The report provides qualitative and quantitative trends of the global Prostate health Market.
The report provides qualitative and quantitative trends of the global Prostate health Market segmented by deployment, component, solution, application, and geography.
Order a copy of this research Prostate health Market research report at @: https://www.businessmarketinsights.com/buy/single/BMIRE00026482
The report starts with the key takeaways, highlighting the key trends and outlook of the global Prostate health Market.
Chapter 3 provides the research methodology of the study.
Chapter 4 provides a brief overview of the Benefits Prostate health Market landscape. It further provides the segmentation of the market with PEST analysis on global scenarios along with ecosystem analysis and expert opinions.
Chapter 5 highlights the Benefits Prostate health Market trends and outlook and the prevailing factors that are driving the market, as well as are deterrents to market growth, along with their impact analysis.
Chapter 6 discusses the market revenue and forecast, in the global Prostate health Market.
Chapter 7, 8, and 9 discuss the market segmented by deployment, application, and geography across the regions.
Chapter 10 provides the impact of COVID 19 across the regions and respective countries.
Chapter 11 provides the industry landscape and highlights the major market events, as well as major market vendors in the ecosystem.
Chapter 12 provides the detailed profiles of the key companies operating within the Benefits Prostate health Market. The companies have been profiled based on their key facts, business descriptions, financial overview, SWOT analysis, and key developments.
Chapter 13, i.e., the appendix is inclusive of a brief overview of the company, glossary of terms, contact information, and the disclaimer section.
The report also covers a detailed chapter of the analysis on COVID-19 impact on this market at the global and regional level in our final reports.
This research provides detailed information regarding the major factors influencing the growth of the Prostate health Market at the Regional Level (drivers, restraints, opportunities, and challenges), forecast of the market size, in terms of value, market share by region and segment; regional market positions; segment and country opportunities for growth; New product developments, strengths, and weaknesses, brand portfolio; Marketing and distribution strategies; challenges and threats from current competition and prospects; Key company profiles, SWOT, product portfolio and growth strategies.
“Business Market Insights” conducts hundreds of primary interviews a year with industry participants and commentators to validate its data and analysis. A typical research interview fulfills the following functions:
Provides First-Hand Information on the Market Size, Market Trends, Growth Trends, Competitive Landscape, and Future Outlook
Validates and Strengthens Secondary Research Findings
Further Develops the Analysis Team’s Expertise and Market Understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
Industry Participants: VPs, Business Development Managers, Market Intelligence Managers and National Sales Managers
Outside Experts: Valuation Experts, Research Analysts and Key Opinion Leaders Specializing in the Industry
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.
If you have any queries about this report or if you would like further information, please
Contact Person: Sameer Joshi
E-Mail ID: [email protected]
Blog URL: https://bmiinsights.blogspot.com/